These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11716473)

  • 41. Prions and prion diseases.
    Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
    Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prion diseases].
    Warter JM; Steinmetz G; Mohr M; Tranchant C
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):998-1007. PubMed ID: 12407310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
    Tayebi M; Hawke S
    Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prion protein interconversions and the transmissible spongiform encephalopathies.
    Horiuchi M; Caughey B
    Structure; 1999 Oct; 7(10):R231-40. PubMed ID: 10545332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding the nature of prion diseases using cell-free assays.
    Lawson VA
    Methods Mol Biol; 2008; 459():97-103. PubMed ID: 18576150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
    Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
    Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmissible spongiform encephalopathies and the 'rogue share-holder protein' hypothesis.
    Sastry PS
    Med Hypotheses; 2000 Feb; 54(2):186-8. PubMed ID: 10790749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amyloidoses of the nervous system in the transmissible dementias.
    Piccardo P
    Arch Med Res; 1992; 23(1):3-6. PubMed ID: 1364059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
    Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
    Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner.
    Relaño-Ginés A; Lehmann S; Bencsik A; Herva ME; Torres JM; Crozet CA
    J Infect Dis; 2011 Oct; 204(7):1038-45. PubMed ID: 21881119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.
    Peretz D; Williamson RA; Kaneko K; Vergara J; Leclerc E; Schmitt-Ulms G; Mehlhorn IR; Legname G; Wormald MR; Rudd PM; Dwek RA; Burton DR; Prusiner SB
    Nature; 2001 Aug; 412(6848):739-43. PubMed ID: 11507642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies.
    Choi YG; Kim JI; Jeon YC; Park SJ; Choi EK; Rubenstein R; Kascsak RJ; Carp RI; Kim YS
    J Biol Chem; 2004 Jul; 279(29):30402-9. PubMed ID: 15084583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
    Crozet C; Lin YL; Mettling C; Mourton-Gilles C; Corbeau P; Lehmann S; Perrier V
    J Cell Sci; 2004 Nov; 117(Pt 23):5591-7. PubMed ID: 15494372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmissible spongiform encephalopathies: virally transmitted amyloidoses.
    Diringer H; Oberdieck U; Malchow M; Beekes M
    Dev Biol Stand; 1993; 80():25-9. PubMed ID: 8270112
    [No Abstract]   [Full Text] [Related]  

  • 60. CNS pathogenesis of prion diseases.
    Brandner S
    Br Med Bull; 2003; 66():131-9. PubMed ID: 14522855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.